Page last updated: 2024-12-06

1,2-dithiol-3-thione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2-Dithiol-3-thione (DTT)

1,2-Dithiol-3-thione, often abbreviated as DTT, is a small organic molecule with a distinctive chemical structure. It contains a five-membered ring with three sulfur atoms and two carbon atoms. DTT is **highly reactive and is commonly used as a reducing agent in various scientific fields.**

**Here's why DTT is important for research:**

**1. Breaking Disulfide Bonds:**

* DTT is a powerful reducing agent, meaning it can donate electrons to other molecules.
* It efficiently cleaves disulfide bonds (-S-S-) found in proteins and other molecules.
* This property makes DTT crucial in:
* **Protein biochemistry:** Denaturing proteins and disrupting their structure for analysis.
* **Molecular biology:** Reducing disulfide bonds in DNA and RNA to aid in their analysis and manipulation.

**2. Protecting Proteins from Oxidation:**

* DTT can also prevent the oxidation of proteins by reacting with reactive oxygen species (ROS).
* This is important for preserving protein structure and function, especially in biological studies.

**3. Studying Protein Structure and Function:**

* DTT is widely used in techniques like gel electrophoresis, chromatography, and mass spectrometry.
* By reducing disulfide bonds, DTT can alter protein conformation and help researchers analyze protein structure, interactions, and function.

**4. Applications in Drug Discovery and Development:**

* DTT's reducing properties have applications in drug design and development.
* It can be used to study the stability and activity of potential drug candidates.

**5. Studying Redox Biology:**

* DTT is used in redox biology research to investigate the role of redox reactions in various biological processes.
* It can be used to study the effects of redox stress on cells and organisms.

**Overall, 1,2-dithiol-3-thione (DTT) is a versatile tool with broad applications in many areas of scientific research. Its ability to break disulfide bonds and protect proteins from oxidation makes it indispensable for studying biological molecules, proteins, and their interactions.**

1,2-dithiol-3-thione: has antioxidant activity; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68296
CHEMBL ID368700
CHEBI ID50866
SCHEMBL ID362931
MeSH IDM0141373

Synonyms (29)

Synonym
CHEBI:50866 ,
inchi=1/c3h2s3/c4-3-1-2-5-6-3/h1-2
3h-1,2-dithiole-3-thione
534-25-8
1,2-dithiolene-3-thione
1,2-dithiole-3-thione
dithiole-3-thione
NCGC00095291-01
NCGC00095291-02
1,2-dithiol-3-thione
einecs 208-595-0
SPECTRUM1505015
3-h-1,2-dithiole-2-thione (d3t); 1,2-dithiol-3-thione
FT-0667743
dithiolethione
CHEMBL368700
AKOS004907024
unii-wt2qf220rr
wt2qf220rr ,
BRD-K91781484-001-01-3
CCG-207972
SCHEMBL362931
J150.687K ,
DTXSID7037052
dithiole-3-thione, 1,2-
1,2-dithia-4-cyclopentene-3-thione
3-h-1,2-dithiole-2-thione (d3t)
Q26840878
CS-0145792

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Because glutathione (GSH) and GSH S-transferase (GST) are a major cellular defense against the toxic effects of reactive aldehydes, in this study we have characterized the inducibility of GSH and GST by the unique chemoprotective agent, 3H-1,2-dithiole-3-thione (D3T) and their protective effects against acrolein-induced toxicity in rat aortic smooth muscle A10 cells."( Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity.
Cao, Z; Hardej, D; Li, Y; Trombetta, LD; Trush, MA, 2003
)
0.32
" They also suffer a range of toxic insults, being a chief target of prooxidants such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenylpyridinium (MPP(+)), 6-hydroxydopamine (6-OHDA), 4-hydroxy-2-nonenal (HNE), and acrolein."( Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein.
Jia, Z; Li, Y; Misra, HP; Zhu, H, 2009
)
0.35

Dosage Studied

ExcerptRelevanceReference
" During the second and third weeks of 1,2-dithiole-3-thione feeding, rats were dosed by gavage with 250 micrograms of AFB1/kg five times a week."( Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Curphey, TJ; Eaton, DL; Groopman, JD; Kensler, TW; Roebuck, BD, 1992
)
0.28
" In wild-type mice, treatment with D3T lead to 3-fold increases in hepatic Nrf2 mRNA levels within several hours following dosing as assessed by Northern blot and RT-PCR analyses."( Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
Itoh, K; Kensler, TW; Kwak, MK; Sutter, TR; Yamamoto, M, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
1,2-dithiole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (34)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency28.18380.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency31.62285.623417.292931.6228AID485281
15-lipoxygenase, partialHomo sapiens (human)Potency7.94330.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency14.12540.141337.9142100.0000AID1490
TDP1 proteinHomo sapiens (human)Potency6.51310.000811.382244.6684AID686978
Microtubule-associated protein tauHomo sapiens (human)Potency15.84890.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency2.23870.011212.4002100.0000AID1030
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency6.30960.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency19.95260.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency18.85410.00798.23321,122.0200AID2546; AID2551
DNA polymerase kappa isoform 1Homo sapiens (human)Potency39.81070.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency10.00000.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency25.11890.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency11.22020.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency19.95260.316212.765731.6228AID881
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency19.95260.00638.235039.8107AID881
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (21)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID492666Ex vivo induction of NQO1 in Sprague-Dawley rat bladder at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID237574Increased quinone reductase specific activity2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
QSAR studies on 1,2-dithiole-3-thiones: modeling of lipophilicity, quinone reductase specific activity, and production of growth hormone.
AID492668Ex vivo induction of NQO1 in Sprague-Dawley rat stomach at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID499306Irreversible inhibition of SHP2 at 10 to 50 uM in presence of 100 mM dithiothreitol2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.
AID492663Ex vivo induction of NQO1 in Sprague-Dawley rat jejunum at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID492664Ex vivo induction of NQO1 in Sprague-Dawley rat ileum at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID499298Competitive inhibition of human PTP1B catalytic subunit assessed as enzyme inactivation at 25 uM after 15 mins by spectrophotometry2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.
AID1173777Neuroprotection against 50 uM 6-hydroxydopamine-induced neurotoxicity in human SH-SY5Y cells assessed as cell viability at 100 uM pre-incubated for 24 hrs before 6-hydroxydopamine challenge2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Synthesis and structure-activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line.
AID237573Increased production of growth hormone2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
QSAR studies on 1,2-dithiole-3-thiones: modeling of lipophilicity, quinone reductase specific activity, and production of growth hormone.
AID492665Ex vivo induction of NQO1 in Sprague-Dawley rat colon at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID237030Partition coefficient (logP)2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
QSAR studies on 1,2-dithiole-3-thiones: modeling of lipophilicity, quinone reductase specific activity, and production of growth hormone.
AID492662Ex vivo induction of NQO1 in Sprague-Dawley rat duodenum at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID1173776Neuroprotection against 25 uM 6-hydroxydopamine-induced neurotoxicity in human SH-SY5Y cells assessed as cell viability at 100 uM pre-incubated for 24 hrs before 6-hydroxydopamine challenge2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Synthesis and structure-activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line.
AID492661Ex vivo induction of NQO1 in Sprague-Dawley rat lung at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID492659Ex vivo induction of NQO1 in Sprague-Dawley rat liver at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID492660Ex vivo induction of NQO1 in Sprague-Dawley rat kidney at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID1173778Toxicity against human SH-SY5Y cells at 100 uM incubated for 24 hrs2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Synthesis and structure-activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line.
AID492667Ex vivo induction of GST in Sprague-Dawley rat bladder at 7.5 umol/kg/day, po for 10 days measured on day 11 relative to control2010Journal of medicinal chemistry, Jun-24, Volume: 53, Issue:12
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
AID1173775Induction of glutathione in human SH-SY5Y cells at 100 uM incubated for 24 hrs by GSH/GSSG Glo assay2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Synthesis and structure-activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.94)18.7374
1990's21 (20.39)18.2507
2000's48 (46.60)29.6817
2010's27 (26.21)24.3611
2020's5 (4.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.93 (24.57)
Research Supply Index4.64 (2.92)
Research Growth Index5.58 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other99 (96.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]